| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/20/1997 | WO1997005898A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
| 02/20/1997 | WO1997005897A1 Remedy for coxsackie virus b infection |
| 02/20/1997 | WO1997005896A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 02/20/1997 | WO1997005895A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | WO1997005894A1 Pharmaceutical composition containing il-10 |
| 02/20/1997 | WO1997005893A1 Remedy for ophthalmic diseases |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005891A1 Use of plasminogene activators to stimulate local bone growth |
| 02/20/1997 | WO1997005890A1 Method of increasing tear production by topical administration of muramyl peptide |
| 02/20/1997 | WO1997005886A1 Compositions for conferring immunogenicity to a peptide |
| 02/20/1997 | WO1997005881A1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 02/20/1997 | WO1997005875A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 02/20/1997 | WO1997005870A2 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | WO1997005771A2 Lysosomal proteins produced in the milk of transgenic animals |
| 02/20/1997 | WO1997002810A3 Polymeric lamellar substrate particles for drug delivery |
| 02/20/1997 | WO1997002730A3 Enamel matrix related polypeptide |
| 02/20/1997 | WO1996040757A3 Lhrh antagonist peptides |
| 02/20/1997 | WO1996038571A3 Recombinant polypeptide cytotoxins for cancer treatment |
| 02/20/1997 | WO1996036711A3 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
| 02/20/1997 | WO1996027005A3 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12 |
| 02/20/1997 | WO1996024345A3 Uses of a vitamin of the k-group against a loss of cognitive faculties |
| 02/20/1997 | DE19529909A1 Wässrige Spüllösung Aqueous washing solution |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2239616A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228909A1 Therapeutic composition for coxsackievirus b infection |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2228620A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | CA2228522A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | CA2228512A1 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | CA2228503A1 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | CA2228379A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 02/20/1997 | CA2227204A1 Human mp52 arg protein |
| 02/20/1997 | CA2221241A1 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 02/20/1997 | CA2202131A1 Therapeutic agent for ophthalmic diseases |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758656A2 Immunoglobulin activated by mixing with a histamine component |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758386A1 Novel enzymatic rna molecules |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |
| 02/19/1997 | EP0758342A1 New peptide active substance and production thereof |
| 02/19/1997 | EP0758341A1 FACTOR Xa INHIBITORS |
| 02/19/1997 | EP0758339A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 02/19/1997 | EP0758248A1 Formulations for factor ix |
| 02/19/1997 | EP0758242A1 Composition and method for treatment of cmv infection |
| 02/19/1997 | EP0758234A1 Method and composition for treating renal disease and failure |
| 02/19/1997 | EP0758233A1 Pde iv inhibitors for treating multiple sclerosis |
| 02/19/1997 | EP0758232A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 02/19/1997 | EP0758227A1 Modulated release from biocompatible polymers |
| 02/19/1997 | EP0758226A1 Red blood cell surrogate |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143325A Method for selective methionine starvation of malignant cells in mammals |
| 02/19/1997 | CN1143116A New human erythropoietin |
| 02/19/1997 | CN1143075A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/18/1997 | USRE35457 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| 02/18/1997 | US5604293 Wound healing and tissue repair |
| 02/18/1997 | US5604207 Sialyl Lex analogues as inhibitors of cellular adhesion |
| 02/18/1997 | US5604204 Method of inducing bone growth using TGF-β |
| 02/18/1997 | US5604203 Analogs of peptide YY and uses thereof |
| 02/18/1997 | US5604202 Use of NGF growth factors to treat drug-induced neuropathy |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604200 Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing |
| 02/18/1997 | US5604198 Parenterally administering conjugate consisting of neurologically active compound conjugated to carrier molecule permeable across said barrier |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604107 Detection of neu p185 in cell lysates |
| 02/18/1997 | US5604106 Testing a body fluid sample with anti-autocrine motility factor antibody |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5604092 Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein |
| 02/18/1997 | US5603951 Cyclosporin-containing soft capsule compositions |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/18/1997 | US5603934 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy |
| 02/18/1997 | US5603933 Peptides including sequence serine-arginine-arginine-serine; capable of binding to hiv glycoprotein |
| 02/18/1997 | US5603932 Receptor of the minor human rhinovirus receptor group |
| 02/18/1997 | US5603931 Administering hybrid reagent comprising first portion having affinity for cellular target and second portion having affinity for bioactive molecule, which can be selectively released in response to change in ph |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005258A2 Recombinant 60kda vegetable panallergen (co-factor-independent phosphoglycerate mutase; e.c. 5.4.2.1.) |
| 02/13/1997 | WO1997005257A1 Peptide analog inhibitors of urokinase receptor activity |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005251A2 Feline stem cell factor |